C4 Therapeutics Inc. (CCCC) Social Stream
C4 THERAPEUTICS INC (CCCC) Price Targets From Analysts
Use the tables below to see what analysts covering C4 THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-28 | 5 | $75 | $45 | $59.333 | $7.28 | 715.01% |
| 2021-11-11 | 5 | $75 | $44 | $59.166 | $7.28 | 712.72% |
| 2021-11-23 | 6 | $75 | $44 | $58.714 | $7.28 | 706.51% |
| 2022-01-03 | 6 | $84 | $44 | $60 | $7.28 | 724.18% |
| 2022-02-08 | 6 | $84 | $40 | $56.142 | $7.28 | 671.18% |
| 2022-02-10 | 8 | $84 | $25 | $52.25 | $7.28 | 617.72% |
| 2022-02-25 | 8 | $84 | $25 | $52.5 | $7.28 | 621.15% |
| 2022-03-10 | 9 | $84 | $25 | $49.666 | $7.28 | 582.23% |
| 2022-03-22 | 9 | $84 | $25 | $48.777 | $7.28 | 570.01% |
| 2022-04-11 | 9 | $84 | $15 | $42.222 | $7.28 | 479.97% |
| 2022-04-12 | 9 | $84 | $15 | $35.777 | $7.28 | 391.44% |
| 2022-05-05 | 9 | $84 | $13 | $31.9 | $7.28 | 338.19% |
| 2022-08-05 | 9 | $84 | $13 | $29.1 | $7.28 | 299.73% |
| 2022-09-17 | 9 | $84 | $13 | $29 | $7.28 | 298.35% |
| 2022-10-11 | 9 | $84 | $6 | $26.909 | $7.28 | 269.63% |
| 2022-10-26 | 10 | $84 | $6 | $26.909 | $7.28 | 269.63% |
| 2022-11-04 | 10 | $84 | $6 | $26.909 | $7.28 | 269.63% |
| 2022-11-07 | 10 | $84 | $6 | $26.181 | $7.28 | 259.63% |
| 2023-01-02 | 10 | $84 | $6 | $24.909 | $7.28 | 242.16% |
| 2023-02-08 | 9 | $84 | $6 | $24.727 | $7.28 | 239.66% |
| 2023-02-24 | 9 | $84 | $6 | $24.727 | $7.28 | 239.66% |
| 2023-03-27 | 9 | $84 | $5 | $23.181 | $7.28 | 218.42% |
| 2023-03-28 | 9 | $84 | $5 | $22.636 | $7.28 | 210.93% |
| 2023-05-04 | 9 | $84 | $5 | $22.555 | $7.28 | 209.82% |
| 2023-05-08 | 9 | $84 | $5 | $21.222 | $7.28 | 191.51% |
| 2023-05-11 | 9 | $84 | $3 | $21 | $7.28 | 188.46% |
| 2023-05-30 | 10 | $84 | $3 | $21 | $7.28 | 188.46% |
| 2023-06-06 | 10 | $84 | $3 | $19.9 | $7.28 | 173.35% |
| 2023-08-08 | 10 | $84 | $3 | $19.909 | $7.28 | 173.48% |
| 2023-08-11 | 10 | $84 | $3 | $17.909 | $7.28 | 146% |
| 2023-10-31 | 10 | $84 | $2 | $17.636 | $7.28 | 142.25% |
| 2023-11-02 | 11 | $84 | $2 | $15.454 | $7.28 | 112.28% |
| 2023-11-03 | 11 | $84 | $2 | $15.454 | $7.28 | 112.28% |
| 2023-11-10 | 11 | $84 | $1 | $15.272 | $7.28 | 109.78% |
| 2023-12-14 | 11 | $84 | $1 | $16.818 | $7.28 | 131.02% |
The Trend in the Analyst Price Target
Over the past 42 weeks, CCCC's average price target has gone down $6.36.
Over the past 46 weeks, CCCC's average upside potential has been 546.55%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-07 | 10 | 84 | 6 | 24.727 | 6.31 | 291.87% |
| 2023-08-08 | 10 | 84 | 3 | 19.909 | 3.51 | 467.21% |
| 2023-10-31 | 10 | 84 | 2 | 17.636 | 1.49 | 1083.62% |
| 2023-11-02 | 11 | 84 | 2 | 15.454 | 1.40 | 1003.86% |
| 2023-11-06 | 11 | 84 | 1 | 15.272 | 1.81 | 743.76% |
CCCC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.91 | 7 | 0 | 3 | 1 | 1 | 11 |
The Trend in the Broker Recommendations
CCCC's average broker recommendation rating worsened by 0.47 over the prior 21 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, C4 THERAPEUTICS INC's variance in analysts' estimates is lower than -3716.73% of them.
- In terms of how C4 THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 3694.98% of that group.
- In terms of how C4 THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 2449.84% of that group.
- C4 THERAPEUTICS INC's average analyst price target is higher than 1792.81% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, ACB, CRON, and SDGR are the three stocks most similar to C4 THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CCCC using the data that counts. Try POWR Ratings for free.